Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC/tumor fusion vaccine in advanced melanoma
NCT00626860Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jul 2000
- Primary completion
- Jan 2002
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Dendritic cell/tumor fusion vaccine in melanoma, sponsored by Beth Israel Deaconess Medical Center. Started Jul 2000; status: completed.
02
Drugs
Dendritic cell/tumor fusion vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00626860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626860.